Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Mulaikal, C. Migeon, John Rock (1987)
Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.The New England journal of medicine, 316 4
J Wyk, D Gunther, E. Ritzén, A. Wedell, G Cutler, C. Migeon, M New (1996)
The use of adrenalectomy as a treatment for congenital adrenal hyperplasia.The Journal of clinical endocrinology and metabolism, 81 9
J. Helleday, B. Siwers, E. Ritzén, Kjell Carlström (1993)
Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency.The Journal of clinical endocrinology and metabolism, 76 4
M. New, R. Wilson (1999)
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.Proceedings of the National Academy of Sciences of the United States of America, 96 22
C. Bergstrand (1966)
Growth in Congenital Adrenal HyperplasiaActa Pædiatrica, 55
M. New, J. Gertner, Phyllis Speiser, P. Balzo (1989)
Growth and final height in classical and nonclassical 21-hydroxylase deficiency.Journal of endocrinological investigation, 12 8 Suppl 3
Holmes Dj, G. Conway, J. Honour, G. Rumsby, H. Jacobs (1995)
Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21‐hydroxylase deficiencyClinical Endocrinology, 43
Cutler (1990)
Congenital adrenal hyperplasia due to 21-hydroxylase deficiencyNew England Journal of Medicine, 27
R. Girgis, J. Winter (1997)
The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.The Journal of clinical endocrinology and metabolism, 82 12
M. Dracopoulou-Vabouli, M. Maniati-Christidi, Catherine Dacou-Voutetakis (2001)
The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia.The Journal of clinical endocrinology and metabolism, 86 6
C. Dacou-voutetakis, D. Klontza, P. Lagos, A. Tzonou, E. Katsarou, S. Antoniadis, G. Papazisis, G. Papadopoulos, N. Matsaniotis (1983)
Age of pubertal stages including menarche in Greek girls.Annals of human biology, 10 6
E. Eugster, L. Dimeglio, James Wright, G. Freidenberg, R. Seshadri, O. Pescovitz (2001)
Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis.The Journal of pediatrics, 138 1
C. Brook (1990)
The management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Clinical endocrinology, 33 4
C. Migeon, P. Donohoue (1991)
Congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. Its molecular basis and its remaining therapeutic problems.Endocrinology and metabolism clinics of North America, 20 2
M. Young, J. Ribeiro, I Hughes (1989)
Growth and body proportions in congenital adrenal hyperplasia.Archives of Disease in Childhood, 64
J. Dimartino-Nardi, E. Stoner, A. O'Connell, M. New (1986)
The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH).European Journal of Endocrinology, 113
L. Laue, D. Merke, Janet Jones, K. Barnes, S. Hill, G. Cutler (1996)
A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.The Journal of clinical endocrinology and metabolism, 81 10
C. Migeon, Amy Wisniewski (2001)
Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Growth, development, and therapeutic considerations.Endocrinology and metabolism clinics of North America, 30 1
I. Silva, C. Kater, C. Cunha, M. Viana (1997)
Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasiaArchives of Disease in Childhood, 77
M. Young, I Hughes (1990)
Response to treatment of congenital adrenal hyperplasia in infancy.Archives of Disease in Childhood, 65
C. Dacou-voutetakis, N. Karidis (1993)
Congenital Adrenal Hyperplasia Complicated by Central Precocious Puberty: Treatment with LHRH‐Agonist AnalogueAnnals of the New York Academy of Sciences, 687
J. Dimartino-Nardi, Elizabeth Stoner, A. O'Connell (1986)
THE EFFECT OF TREATMENT ON FINAL HEIGHT IN CLASSICAL CONGENITAL ADRENAL HYPERPLASIA (CAH)Pediatric Research, 20
E. Charmandari, P. Hindmarsh, A. Johnston, C. Brook (2001)
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.The Journal of clinical endocrinology and metabolism, 86 6
M. Kleerekoper, R. Schiebinger, J. Gutai (1997)
Steroid therapy for adrenal disorders--getting the dose right.The Journal of clinical endocrinology and metabolism, 82 12
F. Cameron, B. Kaymakci, Edwin Byrt, P. Ebeling, G. Warne, J. Wark (1995)
Bone mineral density and body composition in congenital adrenal hyperplasia.The Journal of clinical endocrinology and metabolism, 80 7
T. Cole, J. Freeman, M. Preece, Mrc Dunn (1995)
Body mass index reference curves for the UK, 1990.Archives of Disease in Childhood, 73
L. Premawardhana, I. Hughes, G. Read, M. Scanlon (1997)
Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experienceClinical Endocrinology, 46
A. Tanae, I. Hibi (1988)
Unresolved problems in the treatment of congenital adrenal hyperplasia.Acta paediatrica Japonica : Overseas edition, 30 Suppl
D. Merke, Gordon Cutler (1997)
New approaches to the treatment of congenital adrenal hyperplasia.JAMA, 277 13
G. Clayton (1986)
Patterns of growth from birth to maturity in infants and children with congenital adrenal hyperplasia.Acta endocrinologica. Supplementum, 279
(1977)
Growth patterns in congenital adrenal hyperplasia. Correlation of glucocorticoid therapy with stature
O. Pescovitz, F. Cassorla, F. Comite, D. Loriaux, G. Cutler (1985)
LHRH Analog Treatment of Central Precocious Puberty Complicating Congenital Adrenal HyperplasiaAnnals of the New York Academy of Sciences, 458
B. Linder, P. Feuillan, G. Chrousos (1989)
Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.The Journal of clinical endocrinology and metabolism, 69 1
G. Klingensmith, Silvia Garcia, H. Jones, C. Migeon, R. Blizzard (1977)
Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility.The Journal of pediatrics, 90 6
I. Hughes (1990)
Monitoring treatment in congenital adrenal hyperplasia.Archives of Disease in Childhood, 65
Acm Yu, D. Grant (1995)
Adult height in women with early‐treated congenital adrenal hyperplasia (21‐hydroxylase type): relation to body mass index in earlier childhoodActa Pædiatrica, 84
R. Sandrini, Nicholas Jospe, C. Migeon (1993)
Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt‐losing congenital virilizing adrenal hyperplasia due to 21‐hydroxylase deficiencyActa Pædiatrica, 82
J. Tanner, R. Whitehouse, M. Takaishi (1966)
Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II.Archives of Disease in Childhood, 41
Ashraf Soliman, Mohammed AlLamki, I. Alsalmi, Maurice Asfour (1997)
Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog.Metabolism: clinical and experimental, 46 5
J. Jääskeläinen, R. Voutilainen (1997)
Growth of Patients with 21-Hydroxylase Deficiency: An Analysis of the Factors Influencing Adult HeightPediatric Research, 41
C. Brook (1990)
CURRENT THERAPY THE MANAGEMENT OF CLASSICAL CONGENITAL ADRENAL HYPERPLASIA DUE TO 21‐HYDROXYLASE DEFICIENCYClinical Endocrinology, 33
J. Tanner, R. Whitehouse, M. Takaishi (1966)
Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I.Archives of Disease in Childhood, 41
R. Cornean, P. Hindmarsh, C. Brook (1998)
Obesity in 21-hydroxylase deficient patientsArchives of Disease in Childhood, 78
D. Merke, G. Cutler (2001)
New ideas for medical treatment of congenital adrenal hyperplasia.Endocrinology and metabolism clinics of North America, 30 1
M. Maresh, A. Washburn (1950)
Radiographic Atlas of Skeletal Development of the Hand and WristPediatrics, 6
W. Krogman (1951)
Radiographic Atlas of Skeletal Development of the Hand and WristPhysical Therapy, 31
objective The management of children with congenital adrenal hyperplasia (CAH) remains a challenge, especially with regard to growth potentials. The objective of our analysis was to uncover the factors that influence the growth and final height of patients with CAH.
Clinical Endocrinology – Wiley
Published: Jan 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.